To decrease the bystander edits, scientists used a specific ABE (NG-ABEmax) which was delivered as mRNA. The NG-ABEmax RNA approach was validated in patient-derived rectal organoids and bronchial epithelial cells showing sufficient gene correction to recover the CFTR function.
[Molecular Therapy]